Article
Paetheon raises additional $5.8 million from over-allotment stock sale
November 9, 2000
RBC Dominion Securities Inc., CIBC World Markets Inc., Paradigm Capital Inc., and Canaccord Capital Corp. have exercised an over-allotment option granted in connection with Patheon Inc.'s (Toronto) recent offering of approximately 2.8 million common shares. The option allowed the companies to purchase an additional 412,500 common shares of Patheon stock at $14 per share. Patheon raised aggregate gross proceeds of approximately $5.8 million from the transaction, which was completed yesterday.
With the exercise of the over-allotment option, the offering totaled over $44 million in total gross proceeds.
Patheon is an independent global provider of drug manufacturing and development services in the pharmaceutical outsourcing sector. Patheon operates eight cGMP facilities in Canada and Europe.
For more information, contact Robert C. Tedford, CEO of Patheon, at 905-812-6760.
Edited by Jim Pomager
Assistant Editor, Pharmaceutical Online
Visit the Patheon storefront on Pharmaceutical Online.
